Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Vomiting 1Rectal Neoplasms 1Patient Compliance 1Nausea 1Liver Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Acupuncture Points × Gastrointestinal × Clear all
NCT00430313 2023-03-29

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

M.D. Anderson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Liver Neoplasms, Nausea, Vomiting

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown
264 enrolled
Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡